Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational Study.

Autor: Hill JA; Vaccine and Infectious Disease, Fred Hutchinson Cancer Center, and Department of Medicine, University of Washington, Seattle, Washington, USA., Martens MJ; Center for International Blood and Marrow Transplantation Research, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.; Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Young JH; Division of Infectious Diseases, University of Minnesota, Minneapolis, Minnesota, USA., Bhavsar K; Center for International Blood and Marrow Transplantation Research, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Kou J; Center for International Blood and Marrow Transplantation Research, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Chen M; Center for International Blood and Marrow Transplantation Research, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Lee LW; Adaptive Biotechnologies Corporation, Seattle, Washington, USA., Baluch A; Division of Infectious Diseases, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Dhodapkar MV; Department of Hematology and Medical Oncology, School of Medicine, Emory University, Atlanta, Georgia, USA., Nakamura R; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, California, USA., Peyton K; The Emmes Company, Rockville, Maryland, USA., Howard DS; Division of Hematology and Oncology, Wake Forest Baptist, Winston-Salem, North Carolina, USA., Ibrahim U; Division of Hematology and Medical Oncology, Mount Sinai Hospital, New York, New York, USA., Shahid Z; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Armistead P; Division of Hematology, University of North Carolina Medical Center, Chapel Hill, North Carolina, USA., Westervelt P; Division of Oncology, Barnes-Jewish Hospital, Washington University, St. Louis, Missouri, USA., McCarty J; Division of Hematology, Oncology & Palliative Care, Virginia Commonwealth University, Richmond, Virginia, USA., McGuirk J; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas, Lawrence, Kansas, USA., Hamadani M; Division of Hematology & Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., DeWolf S; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Hosszu K; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Sharon E; National Cancer Institute, Bethesda, Maryland, USA., Spahn A; National Marrow Donor Program/Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota, USA., Toor AA; Lehigh Valley Health Network, Allentown, Pennsylvania, USA., Waldvogel S; National Marrow Donor Program/Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota, USA., Greenberger LM; The Leukemia and Lymphoma Society, Rye Brook, New York, New York, USA., Auletta JJ; National Marrow Donor Program/Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota, USA.; Division of Hematology/Oncology/BMT and Infectious Diseases, Nationwide Children's Hospital, Columbus, Ohio, USA., Horowitz MM; Center for International Blood and Marrow Transplantation Research, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Riches ML; Center for International Blood and Marrow Transplantation Research, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Perales MA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Aug 16; Vol. 79 (2), pp. 542-554.

Corrigendum to "Designing and conducting a clinical trial in blood and marrow transplantation" [Best Pract Res Clin Haematol 36 (2023) 101471].

Autor: Martens MJ; Division of Biostatistics, Institute for Health & Equity, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, 53226, USA; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, USA. Electronic address: mmartens@mcw.edu., Gao Y; Division of Biostatistics, Institute for Health & Equity, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, 53226, USA. Electronic address: yagao@mcw.edu., Szabo A; Division of Biostatistics, Institute for Health & Equity, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, 53226, USA. Electronic address: aszabo@mcw.edu.

Publikováno v: Best practice & research. Clinical haematology [Best Pract Res Clin Haematol] 2024 Mar; Vol. 37 (1), pp. 101538. Date of Electronic Publication: 2024 Feb 02.

Incidence and Impact of Fungal Infections in Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis and Haploidentical Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis.

Autor: Papanicolaou GA; Infectious Diseases Service, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medicine, New York, New York. Electronic address: papanicg@mskcc.org., Chen M; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin., He N; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin., Martens MJ; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin., Kim S; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin., Batista MV; AC Camargo Cancer Center, Sao Paulo, Brazil., Bhatt NS; University of Washington School of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Hematti P; Division of Hematology/Oncology, BMT & Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin., Hill JA; Fred Hutchinson Cancer Center, Seattle, Washington; University of Washington School of Medicine, Seattle, Washington., Liu H; Division of Hematology, Medical Oncology and Palliative Care, Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin., Nathan S; Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, Chicago, Illinois., Seftel MD; Department of Medicine, University of British Columbia, Vancouver, Canada., Sharma A; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee., Waller EK; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia., Wingard JR; Division of Hematology & Oncology, Department of Medicine, University of Florida, Gainesville, Florida., Young JH; Division of Infectious Disease and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota., Dandoy CE; Cincinnati Children's Hospital Medical Center, University of Cincinnati School of Medicine, Cincinnati, Ohio., Perales MA; Department of Medicine, Weill Cornell Medicine, New York, New York; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Chemaly RF; The University of Texas, MD Anderson Cancer Center, Houston, Texas., Riches M; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin., Ustun C; Division of Hematology/Oncology/Cell Therapy, Rush University, Chicago, Illinois.

Publikováno v: Transplantation and cellular therapy [Transplant Cell Ther] 2024 Jan; Vol. 30 (1), pp. 114.e1-114.e16. Date of Electronic Publication: 2023 Sep 28.

Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 Study.

Autor: Versluis J; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands., Saber W; Medical College of Wisconsin, Milwaukee, WI., Tsai HK; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Gibson CJ; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Dillon LW; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Mishra A; Moffitt Cancer Center, Tampa, FL., McGuirk J; University of Kansas Cancer Center, Kansas City, KS., Maziarz RT; Oregon Health and Science University, Portland, OR., Westervelt P; Washington University in Saint Louis, Saint Louis, MO., Hegde P; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Mukherjee D; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Martens MJ; Medical College of Wisconsin, Milwaukee, WI., Logan B; Medical College of Wisconsin, Milwaukee, WI., Horowitz M; Medical College of Wisconsin, Milwaukee, WI., Hourigan CS; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.; Myeloid Malignancies Program, National Institutes of Health, Bethesda, MD., Nakamura R; City of Hope National Medical Center, Duarte, CA., Cutler C; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Lindsley RC; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Oct 01; Vol. 41 (28), pp. 4497-4510. Date of Electronic Publication: 2023 Aug 22.